DCGI cracks down on indirect promotion of weight-loss prescription drugs
New Delhi: The Drugs Controller General of India (DCGI) has directed all pharmaceutical manufacturers and importers to immediately…
Delaware approves $200 copay for weight-loss drugs
Why Should Delaware Care?Delaware began to cover commercial weight-loss drugs like Ozempic and Wegovy for state employees as…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
Tamannaah Bhatia’s Trainer Shares 3 Foods You Should Skip Before Workout
What you eat before a workout can have a significant impact on your energy levels and overall performance.…
Has anyone died from taking GLP-1 weight-loss drugs? – Baltimore Sun
Has anyone died from taking GLP-1 weight-loss drugs? Baltimore SunPAHO calls for strengthened pharmacovigilance following reports of misuse of…
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
India’s anti-obesity drug market is on the brink of a major transformation, with prices of popular weight-loss medications…
Table 2.0: Restaurants absorb ‘Ozempic effect’ for weight-loss drug consumers
New Delhi:Dozens of Indian restaurants and cafe chains are fast-tracking Size O menus — the O standing for…
Weight Loss Drugs Challenge Big Food As Diets Change
Weight Loss Drugs Challenge Big Food As Diets Change – Moby Americans are making healthier choices, and Big…
Wegovy maker sues rival over ‘knock-off’ weight-loss drugs
[Getty Images] The maker of Ozempic and Wegovy is suing a rival firm for selling what it says…
The side effect of weight loss jabs you shouldn’t ignore
Up to 50% of patients are affected by this common side effect of weight loss drugs. (Fabio Camandona…
Weight loss jab to launch stronger dosage as UK demand set to soar
The UK’s medicines regulator has approved a stronger dose of the weight loss jab Wegovy as demand for…
Eli Lilly’s Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief
Retatrutide’s recent trial results suggest it may be even better than Eli Lilly’s already approved GLP-1 medication, tirzepatide.…